GlaxoSmithKline(GSK)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE 100

Market Cap

£67,856m

Change Today

Price Up8.50p

Share Price

1,296.50p

Sector movers: Drugs groups still buzzing

Date: Thursday 03 Jul 2008

LONDON (ShareCast) - Pharmaceutical stocks move up again, with AstraZeneca boosted by brokers Goldman Sachs and ING upping their respective target prices on the stock to 2,400p and 2,300p.

Investors are steering clear of miners as metals prices slide. The likes of Rio Tinto and BHP Billiton are lower in line with copper prices which tumbled on the dollar’s rebound, while South Africa-focused platinum miner Lonmin came back as prices for the precious metal also slipped.

Top performing sectors so far today
Pharmaceuticals & Biotechnology 7,537.30 +2.77%
Fixed Line Telecommunications 2,773.90 +1.89%
Life Insurance 3,958.90 +1.75%
Tobacco 21,864.70 +1.47%

Bottom performing sectors so far today
Forestry & Paper 2,816.70 -3.33%
Industrial Metals 7,604.70 -2.41%
Industrial Engineering 3,369.50 -2.26%
Mining 24,531.90 -1.69%

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,296.50p Price Up
Change Today +8.50p
52 Week High 1,385.00p
52 Week Low 1,001.00p
Volume 14,151,337
Shares Issued 5,234m
Market Cap £67,856m
Beta 0.57
RiskGrade 121

Performance Indicators

Compare performance with the sector and the market.
Find out more
Key: vs Market vs Sector
Value
69.51% below the market average69.51% below the market average69.51% below the market average69.51% below the market average69.51% below the market average
54.22% above the sector average54.22% above the sector average54.22% above the sector average54.22% above the sector average54.22% above the sector average
Price Trend
66.70% above the market average66.70% above the market average66.70% above the market average66.70% above the market average66.70% above the market average
64.44% above the sector average64.44% above the sector average64.44% above the sector average64.44% above the sector average64.44% above the sector average
Income
24.04% above the market average24.04% above the market average24.04% above the market average24.04% above the market average24.04% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Growth
64.39% below the market average64.39% below the market average64.39% below the market average64.39% below the market average64.39% below the market average
78.08% below the sector average78.08% below the sector average78.08% below the sector average78.08% below the sector average78.08% below the sector average
Price Chg 6m
85.87% above the market average85.87% above the market average85.87% above the market average85.87% above the market average85.87% above the market average
75.56% above the sector average75.56% above the sector average75.56% above the sector average75.56% above the sector average75.56% above the sector average
P/E
8.34% below the market average8.34% below the market average8.34% below the market average8.34% below the market average8.34% below the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
PEG Not Available
Dividend Yield
12.70% above the market average12.70% above the market average12.70% above the market average12.70% above the market average12.70% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
EPS Growth Not Available
Operating Margin
58.47% above the market average58.47% above the market average58.47% above the market average58.47% above the market average58.47% above the market average
97.40% above the sector average97.40% above the sector average97.40% above the sector average97.40% above the sector average97.40% above the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 14
Sell 7
Strong Sell 3
Total 31
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q2 Q1
Ex-Div 30-Jul-08 30-Apr-08
Paid 09-Oct-08 10-Jul-08
Amount 13.00p 13.00p

Trades for 29-Aug-2008

Time Volume / Share Price
16:37 28,268 @ 1,294.75p
16:37 10,026 @ 1,294.55p
10:11 25 @ 1,285.50p
16:39 7,390 @ 1,295.85p
16:52 7,390 @ 1,295.85p

GlaxoSmithKline Key Personnel

CEO Jean-Pierre Garnier
CFO Julian Heslop
Chair Moncef Slaoui

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).